PL3886579T3 - Leczenie narządów ex vivo z użyciem cząsteczek peg-fosfolipidów - Google Patents

Leczenie narządów ex vivo z użyciem cząsteczek peg-fosfolipidów

Info

Publication number
PL3886579T3
PL3886579T3 PL19889740.7T PL19889740T PL3886579T3 PL 3886579 T3 PL3886579 T3 PL 3886579T3 PL 19889740 T PL19889740 T PL 19889740T PL 3886579 T3 PL3886579 T3 PL 3886579T3
Authority
PL
Poland
Prior art keywords
peg
phospholipid molecules
vivo organ
organ treatment
treatment
Prior art date
Application number
PL19889740.7T
Other languages
English (en)
Inventor
Bo Nilsson
Kristina NILSSON EKDAHL
Marianne JENSEN WAERN
Yuji Teramura
Alireza BIGLARNIA
Original Assignee
Icoat Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=70851858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3886579(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icoat Medical Ab filed Critical Icoat Medical Ab
Publication of PL3886579T3 publication Critical patent/PL3886579T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Physiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
PL19889740.7T 2018-11-30 2019-11-29 Leczenie narządów ex vivo z użyciem cząsteczek peg-fosfolipidów PL3886579T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1851492 2018-11-30
PCT/SE2019/051215 WO2020112018A1 (en) 2018-11-30 2019-11-29 Ex vivo organ treatment with peg-phospholipid molecules

Publications (1)

Publication Number Publication Date
PL3886579T3 true PL3886579T3 (pl) 2023-08-28

Family

ID=70851858

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19889740.7T PL3886579T3 (pl) 2018-11-30 2019-11-29 Leczenie narządów ex vivo z użyciem cząsteczek peg-fosfolipidów

Country Status (13)

Country Link
US (1) US20220022447A1 (pl)
EP (1) EP3886579B1 (pl)
JP (1) JP7465567B2 (pl)
KR (1) KR20210097114A (pl)
CN (1) CN113056193B (pl)
AU (1) AU2019390222B2 (pl)
BR (1) BR112021009984A2 (pl)
CA (1) CA3120057A1 (pl)
ES (1) ES2949977T3 (pl)
IL (1) IL283265B1 (pl)
MX (1) MX2021005859A (pl)
PL (1) PL3886579T3 (pl)
WO (1) WO2020112018A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113056193B (zh) 2018-11-30 2022-12-20 爱科特医药公司 用peg磷脂分子的离体器官处理
US20220401566A1 (en) * 2020-01-15 2022-12-22 Icoat Medical Ab Peg-lipid
CN114225115B (zh) * 2021-09-27 2023-03-17 南开大学 无损修饰的含有活细胞的血管替代物及制备方法
WO2023244552A1 (en) * 2022-06-15 2023-12-21 Virginia Commonwealth University Methods for fluid resuscitation of an organ donor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2301921A1 (en) * 1997-08-20 1999-02-25 John Graham Goddard Compositions containing polyethylene glycol and uses thereof
US7029839B2 (en) 2003-04-23 2006-04-18 Human Biosystems Methods and solutions for storing donor organs
JPWO2006093314A1 (ja) 2005-03-04 2008-08-07 国立大学法人 東京医科歯科大学 臓器機能維持改善液
WO2012128696A1 (en) 2011-03-23 2012-09-27 Vivoline Medical Ab Apparatus for maintaining a harvested organ viable and transportable
WO2014059316A1 (en) * 2012-10-12 2014-04-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions and methods for organ preservation
CN103626993B (zh) * 2013-11-05 2016-01-20 南京理工大学 聚乙二醇单甲醚大豆磷脂酰乙醇胺衍生物及其制备
CN113056193B (zh) 2018-11-30 2022-12-20 爱科特医药公司 用peg磷脂分子的离体器官处理

Also Published As

Publication number Publication date
WO2020112018A1 (en) 2020-06-04
CN113056193B (zh) 2022-12-20
ES2949977T3 (es) 2023-10-04
EP3886579A4 (en) 2022-09-07
IL283265B1 (en) 2024-04-01
CA3120057A1 (en) 2020-06-04
EP3886579C0 (en) 2023-06-07
IL283265A (en) 2021-07-29
AU2019390222B2 (en) 2023-12-14
EP3886579B1 (en) 2023-06-07
MX2021005859A (es) 2021-07-16
AU2019390222A1 (en) 2021-05-27
EP3886579A1 (en) 2021-10-06
BR112021009984A2 (pt) 2021-08-17
JP7465567B2 (ja) 2024-04-11
JP2022511767A (ja) 2022-02-01
CN113056193A (zh) 2021-06-29
KR20210097114A (ko) 2021-08-06
US20220022447A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
IL269027A (en) Treatment of tumors that express LAG-3
IL283265A (en) Treatment of an organ outside the body using peg-phospholipid molecules
IL273550A (en) Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3
EP3307329A4 (en) CANCER TREATMENT AND DIAGNOSIS
IL266690A (en) Agents targeting selected organs and tissues
GB201903546D0 (en) Cancer treatment
IL280677A (en) Tissue treatment with a substance that causes sensitivity and light and/or sound
IL280876A (en) Aromatic molecules for use in the treatment of pathological conditions
IL287652A (en) Cancer treatment
IL285466A (en) Cancer treatment
EP3648693A4 (en) MEDICAL INSTRUMENT FOR IN VIVO
IL279277A (en) In vivo controlled combination therapy for treatment of cancer
IL269121A (en) Usl-311 for use in the treatment of cancer
EP3615003A4 (en) DIAGNOSIS AND TREATMENT OF VITILIGO
IL280872A (en) Aromatic molecules for use in the treatment of pathological conditions
GB201819920D0 (en) Cancer treatment
EP3314021A4 (en) HISTONE MODIFICATION AGENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
GB2586577B (en) Diagnosis and treatment
GB201906975D0 (en) Treatment of ards
KR102389953B9 (ko) 편리성이 증진된 마스크팩
ZA202001435B (en) Abx196 for use in the treatment of bladder cancer
GB201801195D0 (en) Skin repair treatment
GB201910644D0 (en) Cancer Treatment
GB201907149D0 (en) Cancer treatment
GB201811431D0 (en) Cancer treatment